Applied Clinical Trials podcast

ACT Brief: Community Research Financing Gaps, Neuroscience Endpoint Data, and Teva’s Biosimilar Deal

0:00
1:57
Rewind 15 seconds
Fast Forward 15 seconds
In today’s ACT Brief, we examine why community research needs lasting financing and infrastructure, how electronic outcome tools can strengthen neuroscience endpoints, and how Teva is licensing two biosimilars from Samsung Bioepis.

More episodes from "Applied Clinical Trials"